An application to the FDA for approval to market a biologic in the U.S. The FDA determines if a protein pharmaceutical is considered a biologic or a drug, and whether a PLA or an NDA, respectively, should be filed to obtain marketing approval. ... (14 Nov 1997) ... Found on http://www.encyclo.co.uk/local/20973